GAA and glycogen storage disease II: Enzyme replacement therapy (ERT) with recombinant human GAA (rhGAA), derived from Chinese hamster ovary (CHO) cells, was approved as registered treatment for patients with Pompe disease in 2006 (Myozyme, Genzyme Corporation).